| Literature DB >> 29940921 |
Yan Guo1,2,3, Y Alicia Hong4, Jiaying Qiao5, Zhimeng Xu6, Hanxi Zhang7,8,9, Chengbo Zeng7,8,9, Weiping Cai7,8,9, Linghua Li5, Cong Liu6, Yiran Li6, Mengting Zhu6, Nathan Asher Harris9, Cui Yang6.
Abstract
BACKGROUND: People living with HIV (PLWH) suffer from high rates of mental illness; but targeted effective interventions are limited, especially in developing countries. High penetration of smartphone usage and widespread acceptance of social media applications provide an unprecedented opportunity for mobile-based health interventions (mHealth interventions) in resource-limited settings like China. The current report describes the design and sample characteristics of the Run4Love randomized controlled trial (RCT) aimed at improving mental health in PLWH in China.Entities:
Keywords: Depression; Mental health; People living with HIV (PLWH); Randomized controlled trial; mHealth intervention
Mesh:
Year: 2018 PMID: 29940921 PMCID: PMC6019517 DOI: 10.1186/s12889-018-5693-1
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
The adapted 9-session Cognitive-Behavioral Stress-Management (CBSM) course
| Session | Content | Week |
|---|---|---|
| Session 1 | Introduction to the program and stressors and stress responses | 1 |
| Audio Progressive muscle relaxation for 16 muscle groups | ||
| Session 2 | Stress and awareness | 2 |
| Audio Progressive muscle relaxation for 8 muscle groups | ||
| Session 3 | Negative thinking and cognitive distortions | 3 |
| Audio Breathing, imagery, passive progressive muscle relaxation for 4 muscle groups | ||
| Review 1 | Review and course evaluation of session 1, 2, and 3 | 4 |
| Session 4 | Anxiety and depression | 5 |
| Audio Breathing, imagery, passive progressive muscle relaxation | ||
| Session 5 | Rational thought replacement | 6 |
| Audio Autogenic training for heaviness and warmth | ||
| Session 6 | Productive coping and executing effective coping responses | 7 |
| Audio Autogenic training for heartbeat, breathing, abdomen, and forehead | ||
| Review 2 | Review and course evaluation of session 4, 5, and 6 | 8 |
| Session 7 | Introduction of meditation | 9 |
| Audio Autogenic training with imagery and self-suggestions | ||
| Session 8 | Anger management | 10 |
| Audio Mantra meditation | ||
| Session 9 | Social support and review of the program | 11 |
| Audio Imagery and meditation | ||
| Review 3 | Review and course evaluation of all sessions | 12 |
Fig. 1WeChat users’ interfaces in the Run4Love study
Measures and schedule of Run4Love outcome assessments
| Schedule | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Domain | Measure | Items | Alphaa | 0 mo | 1 mo | 2 mo | 3 mo | 6 mo | 9 mo |
| Demographics | Age, gender, height, weight, education, sexual orientation, marital status, employment, daily expenses affordability, HIV infection duration | 10 | n/a | X | |||||
| Depression | Center for Epidemiological Studies Depression Scale (CES-D)b | 20 | 0.90 | X | X | X | X | ||
| Patient Health Questionnaire (PHQ-9)c | 9 | 0.86 | X | X | X | X | X | X | |
| Physical activity | Global Physical Activity Questionnaire (GPAQ)d | 16 | 0.85 | X | X | X | X | ||
| Quality of Life | World Health Organization Quality of Life HIV short version (WHOQOL-HIV BREF)e | 31 | 0.85 | X | X | X | X | ||
| Self-efficacy | General Self-efficacy Scale (GSES)f | 10 | 0.87 | X | X | X | X | ||
| Stress | Perceived Stress Scale (PSS)g | 10 | 0.83 | X | X | X | X | ||
| Hair cortisol (biomarker) | n/a | n/a | X | X | |||||
| HIV-related stigma | HIV Stigma Scaleh | 14 | X | X | X | X | |||
| *Internalized stigma (8 items) | 0.92 | ||||||||
| *Perceived stigma (6 items) | 0.90 | ||||||||
| Coping | Simplified Ways of Coping Questionnaire (SWCQ)i | 20 | X | X | X | X | |||
| *Positive coping (12 items) | 0.89 | ||||||||
| *Negative coping (6 items) | 0.78 | ||||||||
| Satisfaction | Intervention-specific satisfaction | 20 | n/a | X | |||||
aCronbach’s coefficient alpha for internal reliability of the scale; n/a = not applicable
bCES-D scores range 0–27; higher scores indicate more severe depressive symptoms
cPHQ-9 scores range 0–60; higher scores indicate more severe depressive symptoms
dGPAQ uses Metabolic equivalents (METs) to measure the intensity of physical activities; higher METs indicate more intensive physical activities
eWHOQOL-HIV BREF scores range 24–120; higher scores indicate better quality of life
fGSES scores range 0–40; higher scores indicate better self-efficacy
gPSS scores range 0–40; higher scores indicate more stress
hHIV Stigma Scale scores range 14–56; higher scores indicate more HIV-related stigma
iSWCQ scores range 0–36 for positive coping and 0–24 for negative coping; higher scores indicate higher levels of coping
Fig. 2Flowchart of Run4Love intervention trial
Baseline characteristics of 300 participants enrolled in the Run4Love study
| Total ( | Intervention ( | Control ( | |
|---|---|---|---|
| Age in years, median (Q1,Q3) | 27.5 (24.5, 31.3) | 27.4 (24.3, 31.1) | 27.8 (24.6, 32.2) |
| Sex, % men | 92.3 | 94.7 | 90.0 |
| BMI, median (Q1,Q3) | 20.1 (18.6, 21.7) | 20.2 (18.7, 21.9) | 19.9 (18.6, 21.3) |
| Education, % > high school | 60.7 | 65.3 | 65.0 |
| Homosexual/bisexual/uncertain,% | 81.7 | 86.7 | 76.7 |
| Married, % | 12.7 | 12.0 | 13.3 |
| Employed, % | 83.7 | 82.0 | 85.3 |
| Daily expenses, % affordable | 85.0 | 86.0 | 84.0 |
| Infection period in years, | 1.7 (0.6, 3.7) | 1.7 (0.6,4.0) | 1.8 (0.6,3.6) |
| CES-D [0–60], | 23.0 (19.0, 28.0) | 23 (19.0, 28.0) | 23 (19.0, 27.0) |
| PHQ-9 depression [0–27] | 10.0 (7.0, 13.0) | 10.0 (7.0, 12.8) | 10.0 (7.0, 13.0) |
| GPAQ physical activity (METs), | 43.3 | 43.3 | 43.3 |
| HIV-related quality of life [24–120], Mean ± Standard deviation | 77.0 ± 9.2 | 77.4 ± 9.0 | 76.6 ± 9.4 |
| GSES Self efficacy [10–40], | 23.0 (20.0, 27.2) | 23.0 (20.0, 28.0) | 23.0 (20.0, 27.0) |
| Perceived stress [0–40], | 20 (18, 23) | 20 (17, 22) | 20 (18, 23) |
| HIV-related Stigma [14–56], | 38.0 (32.0, 42.0) | 37.0 (32.0, 42.0) | 38.0 (34.0, 42.0) |
| Positive coping [0–36], | 18 (14, 22) | 18 (14, 21) | 18 (13.2, 22) |
| Negative coping [0–24], | 12 (9, 15) | 12 (9, 15) | 12 (9, 15) |
| CD4, median (Q1,Q3) | 413 (304, 534) | 416 (309, 536) | 405 (303, 522) |